Speaker(s): 

Kelly Morgan, M.S., Genetic Counselor, Geisinger- has nothing to disclose

Marin Catino-Student, Geisinger- has nothing to disclose

Moderator(s): 

None.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Compare MyCode cohorts with and without previous clinical testing

2. Describe the occurrences of receiving an actionable genomic risk through MyCode not identified on previous clinical testing for a different indication

3. Discuss the patient experience of managing multiple genomic risks 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Cara McCormick, MPH; Adam Buchanan, MS, MPH, LCGC; Juliann Savatt, MS, LCGC; Melissa Kelly, MS, LCGC and Marc Williams, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.